3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Oropharyngeal Neoplasms
4
Head and Neck Neoplasms
3
Lung Neoplasms
2
Glioblastoma
2
Uterine Cervical Neoplasms
1
Tobacco Use Disorder
1
Thymoma
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Smoking Cessation
1
Smoking
1
Sinonasal Squamous Cell Carcinoma
1
Rectal Neoplasms
1
Rectal Malignant Neoplasms
1
Radiation Injuries
1
Postoperative Complications
1
Pathologic Complete Response
1
Papillomavirus Infections
1
Pancreatic Neoplasms
1
Mouth Neoplasms
1
Low Anterior Resection Syndrome
1
Laryngeal Neoplasms
1
Infiltrating Bladder Urothelial Carcinoma
1
HPV-Related Squamous Cell Carcinoma
1
Fatigue
1
Carcinoma, Squamous Cell
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma
1
Interventions
Bevacizumab
56
Cetuximab
50
Fluorouracil
45
Leucovorin
39
Oxaliplatin
38
pembrolizumab
31
Specimen Handling
27
Irinotecan
25
Magnetic Resonance Spectroscopy
17
Biopsy
17
Nivolumab
15
HMPL-013
13
Folfox protocol
13
Capecitabine
13
Gemcitabine
12
Cisplatin
12
trifluridine tipiracil drug combination
11
Panitumumab
11
Carboplatin
11
Pemetrexed
9
IFL protocol
9
encorafenib
8
balstilimab
8
Standard of Care
8
Paclitaxel
8
Early Intervention, Educational
8
130-nm albumin-bound paclitaxel
8
fludarabine
7
atezolizumab
7
Educational Status
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Colorectal Neoplasms
×
Chemoradiotherapy
×
90 days
×
Clear all
No trials found.